Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Glucose Control”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02413398
What this trial is testing

Evaluate the Effect of Dapagliflozin on Blood Glucose Level and Renal Safety in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 321
Large-scale testing (Phase 3)Study completedNCT00434954
What this trial is testing

Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 494
Large-scale testing (Phase 3)Study completedNCT00757588
What this trial is testing

Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin

Who this might be right for
Type 2 Diabetes
AstraZeneca 455
Large-scale testing (Phase 3)Study completedNCT02226003
What this trial is testing

Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 291
Large-scale testing (Phase 3)Study completedNCT02681094
What this trial is testing

A Multi-Center, Randomized, Double-Blind, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin Co-administered With Dapagliflozin Compared to Saxagliptin or Dapagliflozin All Given as add-on Therapy to Metformin in Subject With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusInadequate Glycaemic Control
AstraZeneca 905
Large-scale testing (Phase 3)Study completedNCT05971940
What this trial is testing

Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 559
Post-approval studies (Phase 4)Study completedNCT02589626
What this trial is testing

Long-term Safety and Efficacy of Empagliflozin as Add on to GLP-1 RA

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 65
Testing effectiveness (Phase 2)Study completedNCT02459899
What this trial is testing

Dose-ranging Study in Patients With Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes Mellitus
Lexicon Pharmaceuticals 141
Large-scale testing (Phase 3)Study completedNCT02121717
What this trial is testing

Study of Chiglitazar Compare With Placebo in Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes
Chipscreen Biosciences, Ltd. 535
Large-scale testing (Phase 3)Study completedNCT00095030
What this trial is testing

Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone

Who this might be right for
Diabetes Mellitus, Type 2
Bristol-Myers Squibb 1,752
Large-scale testing (Phase 3)Study completedNCT01704261
What this trial is testing

Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 307
Large-scale testing (Phase 3)Study completedNCT00663260
What this trial is testing

Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 631
Large-scale testing (Phase 3)Study completedNCT00106808
What this trial is testing

Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Bristol-Myers Squibb 1,440
Testing effectiveness (Phase 2)Study completedNCT00263276
What this trial is testing

A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
AstraZeneca 389
Large-scale testing (Phase 3)Looking for participantsNCT07653477
What this trial is testing

Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2)

Who this might be right for
Type 2 Diabetes
The United Bio-Technology (Hengqin) Co., Ltd. 956
Post-approval studies (Phase 4)Study completedNCT00118937
What this trial is testing

Effect of Metformin in Patients With Type-1 Diabetes With Inadequate Glycaemic Control by Insulin and Diet

Who this might be right for
Diabetes Mellitus, Type 1
Steno Diabetes Center Copenhagen 100
Large-scale testing (Phase 3)Study completedNCT06672172
What this trial is testing

HRS-7535 Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Diet and Exercise

Who this might be right for
Type 2 Diabetes
Shandong Suncadia Medicine Co., Ltd. 284
Post-approval studies (Phase 4)Study completedNCT05743907
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing Metformin Monotherapy in Patients with Type 2 Diabetes Who Have Inadequate Glycemic Control

Who this might be right for
Diabetes Mellitus
Dong-A ST Co., Ltd. 231
Large-scale testing (Phase 3)Study completedNCT01703221
What this trial is testing

Omarigliptin (MK-3102) Clinical Trial - Placebo- and Sitagliptin-Controlled Monotherapy Study in Japanese Patients With Type 2 Diabetes Mellitus (MK-3102-020)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 414
Large-scale testing (Phase 3)Study completedNCT00289848
What this trial is testing

MK0431 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-040)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 530
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation